基于术前解剖特征定义II型内漏风险
该研究纳入189例接受标准EVAR的患者,依据术前解剖特征(肠系膜下动脉通畅且直径>3mm、至少3对腰动脉通畅等)分为高危组(65%)和低危组(35%)。高危组36个月免于内漏率更低(p=0.04),48个月免于EII相关再干预率显著更低(80% vs 100%,p=0.001)。多因素回归显示高危组EII风险(OR 9.91)和再干预风险(OR 9.11)更高,且高危组内瘤囊血栓体积<35%为额外预测因子。
要点
- 术前解剖高危标准可有效区分EII低危与高危患者。
- 高危组48个月免于EII再干预率显著低于低危组(80% vs 100%)。
- 高危组内瘤囊血栓体积<35%进一步增加EII及再干预风险。
核心结论
- 基于术前解剖特征的选择标准能有效区分EII低危患者与EII及相关再干预高危患者。
- 在高危组患者中,瘤囊血栓体积<35%是EII及EII相关再干预的额外预测因子。
研究设计与样本
- 回顾性队列研究,纳入2008年1月至2015年12月间189例接受标准EVAR的患者,平均年龄78.4±7.6岁,男性165例。
- 平均动脉瘤直径5.7±0.7 cm,平均体积125.2±45.8 cm3。
- 根据术前解剖标准将患者分为高危组(n=123,65%)和低危组(n=66,35%)。
主要发现
- 高危组36个月免于内漏率低于低危组(p=0.04)。
- 高危组48个月免于EII相关再干预率显著低于低危组(80% vs 100%,p=0.001)。
- 多因素回归显示高危组EII风险更高(OR 9.91,95%CI 2.92-33.72,p<0.001),EII相关再干预风险更高(OR 9.11,95%CI 1.06-78.44,p=0.04)。
- 高危组内瘤囊血栓体积<35%预测EII的OR为5.21(95%CI 1.75-15.47,p=0.003),预测EII相关再干预的OR为8.33(95%CI 2.20-31.51,p<0.002)。
关键数值与推荐
- 高危组定义:至少满足以下一项:肠系膜下动脉通畅且直径>3mm;至少3对腰动脉通畅;2对腰动脉通畅且存在骶动脉或副肾动脉或任何直径的通畅肠系膜下动脉。
- 该标准预测EII的敏感性89.4%(95%CI 83.9%-93.2%),特异性48.0%(95%CI 40.7%-55.3%)。
- 该标准预测EII再干预的敏感性100%(95%CI 93.8%-100%),特异性38.8%(95%CI 31.9%-46.2%)。
临床怎么用
- 术前可依据上述解剖标准识别EII高危患者,考虑预防性措施或更积极的监测方案。
- 对高危组患者,若瘤囊血栓体积<35%,应视为EII及再干预的更高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To define the risk for type II endoleak (EII) after endovascular aneurysm repair (EVAR) based on preoperative anatomical characteristics. METHODS: Between January 2008 and December 2015, 189 patients (mean age 78.4±7.6 years; 165 men) underwent standard EVAR. Mean aneurysm diameter was 5.7±0.7 cm and mean volume 125.2±45.8 cm3. Patients were assigned to the "at-risk" group (n=123, 65%) when at least one of the following criteria was present: patency of a >3-mm inferior mesenteric artery (IMA), patency of at least 3 pairs of lumbar arteries, or patency of 2 pairs of lumbar arteries and a sacral artery or accessory renal artery or any diameter patent IMA; otherwise, patients were entered in the "low-risk" group (n=66, 35%). EII rates and freedom from EII reintervention were compared using Kaplan-Meier curves. Preoperative clinical and anatomical characteristics were evaluated for their association with EII and EII reinterventions using multiple logistic regression analysis; results are presented as the odds ratio (OR) and 95% confidence interval (CI). RESULTS: Freedom from endoleak was lower in the at-risk group compared with the low-risk group at 36 months after EVAR (p=0.04). Freedom from EII-related reinterventions was significantly lower in the at-risk group (80% vs 100%, p=0.001) at 48 months. Based on the multiple regression analysis, the at-risk group had a higher likelihood of both EII (OR 9.91, 95% CI 2.92 to 33.72, p<0.001) and EII-related reinterventions (OR 9.11, 95% CI 1.06 to 78.44, p=0.04). These criteria had 89.4% (95% CI 83.9% to 93.2%) sensitivity and 48.0% (95% CI 40.7% to 55.3%) specificity for EII; sensitivity and specificity for EII reintervention were 100% (95% CI 93.8% to 100%) and 38.8% (95% CI 31.9% to 46.2%). Within the at-risk group, a sac thrombus volume <35% was an additional predictor for both EII (OR 5.21, 95% CI 1.75 to 15.47, p=0.003) and EII-related reinterventions (OR 8.33, 95% CI 2.20 to 31.51, p<0.002). CONCLUSION: The selection criteria effectively discriminated between low-risk patients and patients at risk for EII and associated reinterventions. A thrombus volume <35% was an additional predictor for EII and EII-related reintervention among patients at risk. These criteria may be useful for preemptively selecting patients who may benefit from EII prevention procedures or a more aggressive surveillance protocol.
引用
- Piazza M, Squizzato F, Miccoli T, et al. Definition of Type II Endoleak Risk Based on Preoperative Anatomical Characteristics. J Endovasc Ther. 2017. PMID: 28578623. doi:10.1177/1526602817712511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。